ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.091,84
-0,44%
Dow Jones
44.347,45
-0,49%
Euro vs US Dollar
1,04908
0,72%
Bitcoin
104.863,84
0,86%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Pressure Biosciences Inc (CE) (PBIO)

  7. Pressure Biosciences Inc (CE) (PBIO) News

PBIO

Pressure Biosciences (CE) (PBIO)

Pressure Biosciences Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PBIO
DatumZeitQuelleÜberschriftSymbolFirma
30/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
30/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
30/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
30/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
06/09/202423h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PBIOPressure Biosciences Inc (CE)
19/08/202423h20Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PBIOPressure Biosciences Inc (CE)
17/07/202418h32Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBIOPressure Biosciences Inc (CE)
07/06/202423h28Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:PBIOPressure Biosciences Inc (CE)
27/02/202419h42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:PBIOPressure Biosciences Inc (CE)
25/01/202423h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
08/12/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
20/11/202322h44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PBIOPressure Biosciences Inc (CE)
15/11/202321h18Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
25/10/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
24/10/202316h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
24/10/202316h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
24/10/202316h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
24/10/202316h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
24/10/202316h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBIOPressure Biosciences Inc (CE)
 Showing the most relevant articles for your search:USOTC:PBIO

Kürzlich von Ihnen besucht

BIT
SDTES5
Societe Generale Effekten
BIT
3EUS
WisdomTree EURO STOXX 50...
BIT
1HEN
Henkel AG & Co KGAA
BIT
P1S6Q4
BNP Paribas Issuance
BIT
HGVU
HSBC ICAV Global Gov Bon...
BIT
F20567
Vontobel Financial Produ...
BIT
GLE
Societe Generale
BIT
EGRA
ETF
BIT
PRO
Banco Profilo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten